Agios Pharmaceuticals, Inc. (AGIO) financial statements (2020 and earlier)

Company profile

Business Address 88 SIDNEY STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:718805568574376467194
Cash and cash equivalents8171103161721472
Short-term investments48451532138124532895
Other undisclosed cash, cash equivalents, and short-term investments153220144325912527
Receivables(1)(0) 5813 
Inventory, net of allowances, customer advances and progress billings71    
Inventory71     
Contract with customer, asset9 
Other undisclosed current assets(122)(192)(123)(19)(47)(121)(24)
Total current assets:612614445560337360170
Noncurrent Assets
Finance lease, right-of-use asset1
Operating lease, right-of-use asset94
Property, plant and equipment312424252364
Long-term investments and receivables153220144325912527
Long-term investments153220144325912527
Restricted cash and investments      1
Other noncurrent assets 012110
Total noncurrent assets:279245169598313231
TOTAL ASSETS:891858614619420492201
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities75605749313115
Accounts payable2218231715114
Accrued liabilities5342343216147
Employee-related liabilities     64
Taxes payable      1
Deferred revenue11
Debt7      
Deferred compensation liability      0
Deferred revenue and credits13839223625
Other liabilities     0 
Other undisclosed current liabilities 33   (6)(4)
Total current liabilities:93949588536137
Noncurrent Liabilities
Long-term debt and lease obligation107      
Finance lease, liability1
Operating lease, liability106
Liabilities, other than long-term debt511814417222633
Deferred revenue and credits1814417222633
Deferred revenue51
Other undisclosed noncurrent liabilities 60     
Total noncurrent liabilities:1577714417222633
Total liabilities:250171239261756870
Stockholders' equity
Stockholders' equity attributable to parent641688376359345424131
Common stock0000000
Additional paid in capital2,1561,7941,175842630591245
Accumulated other comprehensive income (loss)0(2)(1)(0)(0)(0)0
Accumulated deficit(1,516)(1,105)(798)(483)(285)(167)(113)
Total stockholders' equity:641688376359345424131
Other undisclosed liabilities and equity      0
TOTAL LIABILITIES AND EQUITY:891858614619420492201

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues118944370596526
Revenue, net4370599226
Cost of revenue
(Cost of Goods and Services Sold)
(1)(1) (0)(0)(0)(0)
Gross profit:117934370596525
Operating expenses(543)(457)(364)(271)(178)(119)(64)
Other undisclosed operating income 1 0000
Operating loss:(426)(362)(321)(201)(119)(54)(39)
Nonoperating income
(Investment Income, Nonoperating)
151663100
Other undisclosed income from continuing operations before equity method investments, income taxes    0  
Loss from continuing operations before equity method investments, income taxes:(411)(346)(315)(198)(118)(54)(39)
Other undisclosed loss from continuing operations before income taxes    (0)  
Loss from continuing operations before income taxes:(411)(346)(315)(198)(118)(54)(39)
Income tax expense (benefit)     0(1)
Net loss attributable to parent:(411)(346)(315)(198)(118)(54)(39)
Preferred stock dividends and other adjustments      (4)
Net loss available to common stockholders, diluted:(411)(346)(315)(198)(118)(54)(44)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(411)(346)(315)(198)(118)(54)(39)
Comprehensive loss:(411)(346)(315)(198)(118)(54)(39)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2(1)(1)0(0)(0)0
Comprehensive loss, net of tax, attributable to parent:(409)(347)(316)(198)(118)(54)(39)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: